ATYR logo

ATYR
aTyr Pharma, Inc

13,344
Mkt Cap
$79.25M
Volume
1,322.00
52W High
$7.29
52W Low
$0.64
PE Ratio
-1.02
ATYR Fundamentals
Price
$0.8083
Prev Close
$0.8276
Open
$0.8247
50D MA
$0.861
Beta
0.79
Avg. Volume
2.1M
EPS (Annual)
-$0.7971
P/B
1.17
Rev/Employee
$3,275.86
$5.97
Loading...
Loading...
News
all
press releases
aTyr Pharma (NASDAQ:ATYR) Upgraded at Wall Street Zen
Wall Street Zen raised shares of aTyr Pharma from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting
aTyr Pharma (NASDAQ:ATYR) CEO Sanjay Shukla outlined the company's strategy to develop new therapies for inflammation and fibrosis based on tRNA synthetase biology during a presentation at the...
MarketBeat·11d ago
News Placeholder
Q1 Earnings Estimate for aTyr Pharma Issued By HC Wainwright
aTyr Pharma, Inc. (NASDAQ:ATYR - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of aTyr Pharma in a research report issued on Friday, March 6th...
MarketBeat·14d ago
News Placeholder
ATYR PHARMA INC Q4 Loss Drops
(RTTNews) - aTYR PHARMA INC (ATYR) reported Loss for fourth quarter of -$13.96 million...
Nasdaq News: Markets·17d ago
News Placeholder
aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
aTyr Pharma (NASDAQ:ATYR - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by...
MarketBeat·18d ago
News Placeholder
aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday
aTyr Pharma (NASDAQ:ATYR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat·18d ago
News Placeholder
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of "Hold" by Analysts
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the company, MarketBeat.com...
MarketBeat·23d ago
News Placeholder
aTyr Pharma (NASDAQ:ATYR) Trading Down 2.1% - Should You Sell?
aTyr Pharma (NASDAQ:ATYR) Shares Down 2.1% - Here's Why...
MarketBeat·26d ago
News Placeholder
Short Interest in aTyr Pharma, Inc. (NASDAQ:ATYR) Drops By 14.7%
aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) was the target of a large decline in short interest in the month of January. As of January 15th, there was short interest totaling 21,334,051 shares...
MarketBeat·2mo ago
News Placeholder
aTyr Pharma, Inc. (NASDAQ:ATYR) Sees Significant Drop in Short Interest
aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totaling...
MarketBeat·2mo ago
<
1
2
...
>

Latest ATYR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.